Vision Screeners in Canada vs the US: Which Screening Device Rules Apply?

Quick facts

• A vision screener sorts patients. It measures acuity, colour response or a crude refractive estimate and passes the result to a clinician; it does not diagnose.
• United States: the chart itself has a device entry. 21 CFR 886.1150 puts a visual acuity chart in Class I, exempt from premarket notification, and the same section carries the digital visual acuity test product code.
• United States: a colour vision tester is also Class I. 21 CFR 886.1170 describes it as colour vision plates or coloured materials intended to evaluate colour vision.
• Canada: no entry names a screener, so the class is derived by rule. A screener that does not touch the eye sits at the low end; a device that contacts the surface of the eye moves to Class II.
• The funding schedule is where the two countries really diverge. In Ontario, the provincial plan covers one major eye examination every 12 months for anyone 19 or younger, and every 18 months for a patient 65 or older without an eligible eye condition.
• A screener is only as good as its consumables. Occluders, wipes, single-use tips and the cleaning routine are what keep a screening lane running between calibrations.

A vision screener is the first instrument a patient meets and the last one anyone buys carefully. It produces a pass or refer result, and in both countries the device sits low in the classification system. The differences that affect a clinic are in who may run the screening, who pays for the examination behind it, and what has to be recorded. This article covers the device, the entries, the funding schedules and the consumables.

What is a vision screener, and what does it not do?

A screener is a triage instrument. It produces a result that separates patients who need a full examination from those who do not, and it is deliberately quick. A refracting lane, by contrast, measures a prescription and is operated by someone trained to interpret what the measurement means.

The distinction matters for four reasons:

• A refer result is not a diagnosis. The screener output becomes a referral; the diagnosis comes from the examination.
• The device may be passive. A printed chart is a device, and so is a printed colour plate set.
• A screener can be powered. Automated and digital instruments sit in the same entry family as the printed chart in the United States.
• The output has to be recorded. A screening programme that cannot show what was measured, when and by whom, cannot be reviewed.

The programme also has to decide what it does with a refer result, because the referral is the part of the process that consumes time and, in a funded system, money. A screening lane with no defined referral pathway produces records rather than outcomes.

How does the classification of a screening device differ between Canada and the United States?

The United States works from a named entry; Canada derives the class from the rules. Both approaches end in a low classification for a screener that does not touch the eye.

Item	Canada	United States
Named entry for a printed acuity chart	None; class derived by rule	21 CFR 886.1150, Class I
Named entry for a colour vision tester	None; class derived by rule	21 CFR 886.1170, Class I
Named entry for a digital acuity test	None; class derived by rule	Same section as the acuity chart
Class for a device that does not touch the eye	Derived, low class	Class I (general controls)
Class for a device that contacts the eye surface	Class II by rule	Separately classified by function
Premarket position	Device licence where the derived class requires it	Exempt from premarket notification inside the entry
Distributor obligation	Establishment licence held by the party placing it on the market	Establishment registration and device listing

Two things follow for a buyer. First, the printed chart is a regulated device in the United States even though it looks like stationery, which is why a clinic that reprints a chart on a home printer has removed the calibration claim from its own record. Second, in Canada the class depends on whether the device touches the patient, so the same catalogue page can list one item at the low end and another as an eye-contact device.

How does the eye examination funding schedule differ between Ontario and the United States?

This is the largest practical difference between the two countries, because the funding schedule decides how a screening referral is followed up.

In Ontario, the provincial plan sets out the intervals in plain terms. Children and youth 19 years old or younger are eligible for one major eye exam every 12 months. A patient 20 or older qualifies for one major exam every 12 months when there is an eligible medical condition affecting the eyes, and a patient 65 or older without such a condition is covered for one major exam every 18 months. In the United States there is no single national schedule of that kind; the interval in practice is set by the patient's plan rather than by a provincial list, and public programmes cover defined groups.

Funding question	Ontario	United States
Is a routine interval set by a public schedule	Yes, published intervals by age and condition	No single national routine schedule
Patient 19 or younger	One major exam every 12 months	Depends on the plan or programme
Patient 20 to 64 with an eligible eye condition	One major exam every 12 months	Depends on the plan or programme
Patient 65 or older, no eligible eye condition	One major exam every 18 months	Depends on the plan or programme
What the clinic must record	The examination and the referral trail	The examination and the payer's documentation

A Canadian clinic that screens children should budget for the follow-up examination, because the funding exists and the referral will be acted on. A clinic working to a plan-driven market should expect the follow-up to depend on the patient's coverage instead.

Instrument	What it measures	United States entry
Printed acuity chart	Distance acuity by graduated optotype size	21 CFR 886.1150, Class I
Digital acuity test	Acuity presented on an automated display	Same section as the printed chart
Colour plate set	Colour vision response	21 CFR 886.1170, Class I
Occluder or paddle	Which eye is being tested	Accessory to the instrument in use

That table is the short version of the purchase file. Each row names an item the screening lane holds, and each item can be traced to the entry that describes it.

Which consumables does a screening lane consume?

The instrument is bought once and the lane is consumables thereafter. The list is short, and each item has a reason to be there.

• Occluders and paddles. Reusable, and therefore cleaned between patients on a documented routine.
• Single-use wipes and swabs. For instrument surfaces and for cleaning the occluder between patients.
• Patient-area supplies. Face masks and hand hygiene supplies for the waiting and screening area.
• Printed charts and cards. A printed acuity chart and a printed colour plate set are both devices, and a laminated set has to be replaced when it fades or scratches.
• The record. The screening result, the date, the instrument and the person who ran it.

Patient-area supplies are reordered as a single line, and the three-ply procedure masks are the item a screening lane runs out of first when a busy week coincides with a supply gap.

For clinics buying these lines at case level, the wholesale ordering page sets out account and case pricing, and the B2B wholesale collection lists what is held for institutional buyers. Practices that also reprocess reusable instruments in house can start with the biological indicator 5-pack trial and read the sterilization monitoring collection for the monitoring lines.

Sources

1. 21 CFR 886.1150, visual acuity chart
2. 21 CFR 886.1170, colour vision tester
3. 21 CFR 886.5925, soft (hydrophilic) contact lens
4. 21 CFR 886.5844, prescription spectacle lens
5. Ontario, what OHIP covers
6. Medical Devices Regulations, SOR/98-282, full text
7. Health Canada, medical devices
8. College of Optometrists of Ontario, standards of practice
9. Opto, Canadian Association of Optometrists eye health library
10. American Optometric Association
11. American Academy of Ophthalmology, eye health
12. Canadian Ophthalmological Society
13. openFDA device classification database
14. Public Health Ontario, infectious diseases
15. Public Health Ontario, test information index
16. CCOHS, needlestick injuries
17. World Health Organization, laboratory biosafety manual
18. Clinical and Laboratory Standards Institute
19. Health Canada, medical device guidance documents
20. Federal Trade Commission, Contact Lens Rule

Related product: Related product: USB heated eye mask with three temperature settings (graphene heating element)

Related reading

• Eye chart in Canada vs the US: which optotype standard applies
• Snellen chart and eye test charts in Canada vs the US: which scale is used
• Ishihara vision test in Canada vs the US: which colour vision rules apply
• Comprehensive eye check-up in Canada vs the US: which exam interval applies

CliniEco Medical supplies eye care, laboratory and clinic consumables of the kind described in this article. Health Canada MDEL #35334. This article is written for clinic, procurement and eye care professionals and is not clinical guidance; screening protocols, referral criteria and diagnosis belong to the treating optometrist or physician.

Frequently Asked Questions

Is a printed eye chart a regulated device?

In the United States it is. The visual acuity chart has its own entry, 21 CFR 886.1150, in Class I and exempt from premarket notification. A clinic that reprints a chart on office paper has replaced a controlled article with an uncontrolled one, and the record no longer describes a device with a basis.

Does Canada name a vision screener in its device rules?

No. The Medical Devices Regulations classify by rule instead of by product name, so a screener takes a class derived from Schedule 1. A screener that does not contact the eye sits low, while anything that contacts the surface of the eye is classified as Class II.

Are colour vision testers classified at the same level?

In the United States a colour vision tester is Class I and exempt from premarket notification under 21 CFR 886.1170, which describes coloured materials and colour vision plates. In Canada the class follows the same derived route as any other ophthalmic device, so the contact question, not the colour technology, decides.

How often does the Ontario plan cover an eye examination?

For anyone 19 or younger, one major eye exam every 12 months. For a patient 20 or older with an eligible medical condition affecting the eyes, one major exam every 12 months. For a patient 65 or older without such a condition, one major exam every 18 months.

Why does the funding schedule matter to a screening programme?

Because a screening result is only useful if the referral behind it can be completed. Where a public schedule sets an interval, a referred patient can usually be seen within that schedule, and the programme can be planned around it. Where coverage is plan-driven, the referral pathway has to be confirmed with the patient first.

Which supplies should a screening lane keep in stock?

Occluders or paddles, single-use wipes and swabs for instrument surfaces, printed charts and colour plates in good condition, patient-area supplies and a record that ties each result to a date and an operator. The instrument is bought once; the lane is kept running by these lines.